United Therapeutics CFO to Present at RBC Healthcare Conference
Event summary
- James Edgemond, CFO of United Therapeutics, will present at the RBC Capital Markets Global Healthcare Conference on May 19, 2026.
- The presentation will run from 9:30 to 9:55 a.m. EST and will be available via live webcast.
- An archived recording will be accessible for 90 days post-event.
- United Therapeutics focuses on rare disease treatments and organ supply expansion.
The big picture
United Therapeutics' presentation at the RBC conference comes at a time when biotech firms are under pressure to demonstrate both financial stability and innovative breakthroughs. As a public benefit corporation, the company's dual focus on patient care and shareholder value will be closely watched. The broader industry trend of advancing rare disease treatments and organ manufacturing technologies adds strategic significance to this update.
What we're watching
- Strategic Updates
- How United Therapeutics' progress in expanding transplantable organ supply will impact its long-term growth prospects.
- Financial Performance
- Whether the company can sustain its commitment to creating long-term shareholder value amid healthcare market volatility.
- Innovation Pace
- The pace at which United Therapeutics can transition from scientific theory to practical, life-saving technologies.
Related topics